Endologix of Irvine, California has received FDA approval to expand its Powerlink system to cover 31 new sizes of main body bifurcated, proximal extension and limb extension stent grafts. The Powerlink system, which we have covered previously, is a unibody stent graft designed for the repair of abdominal aortic aneurysm, and may be deployed using only a single side cut-down. The expanded line will reportedly allow the treating physician greater flexibility in designing personalized treatments and will extend coverage to more unique anatomical configurations. Endologix introduced the expanded line at the 2010 Annual Meeting of the Society for Vascular Surgery, and plans for more widespread adoption in the forth quarter of 2010.
Press release: Endologix Receives FDA Approval for Powerlink Product Line Extensions…
Flashback: Endologix Device for Percutaneous Endovascular Treatment of AAA Begins Trial